At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparative, Randomized, Single-dose, 2-way Cross Over Bioavailability Study of Enoxaparin Sodium Chemi (80 mg/0.8mL) and Clexane® (80 mg/0.8mL) s.c. in Healthy Adult Subjects Under Fasting Conditions.
In Brief
A Phase 1 clinical trial evaluating Enoxaparin Sodium for Enoxaparin Sodium is Administered to Healthy Volunteers. Completed, enrolled 47 participants across 1 site.
Detailed Summary
* The primary objective of the trial is to assess the single-dose relative bioavailability of Chemi Enoxaparin (80 mg/0.8 mL) and Clexane® (80 mg/0.8 mL) administered by subcutaneous (s.c.) injection, under fasting conditions in healthy volunteers. * The secondary objective of the trial is to assess safety and tolerability of Chemi Enoxaparin (80 mg/0.8 mL) and Clexane® (80 mg/0.8 mL) administered by s.c. injection, under fasting conditions in healthy volunteers.
Study Details
Timeline
Interventions
comparison of bioavailability of generic Enoxaparin Sodium and Clexane
comparison of bioavailability of generic Enoxaparin Sodium and Clexane